| Literature DB >> 30670140 |
Aymeric Ung1,2,3, Amrish Y Baidjoe3,4,5, Dieter Van Cauteren1, Nizar Fawal5, Laetitia Fabre5, Caroline Guerrisi6, Kostas Danis1,2, Anne Morand7, Marie-Pierre Donguy7, Etienne Lucas1, Louise Rossignol6, Sophie Lefèvre5, Marie-Léone Vignaud8, Sabrina Cadel-Six8, Renaud Lailler8, Nathalie Jourdan-Da Silva1,9, Simon Le Hello5,9.
Abstract
On 18 January 2016, the French National Reference Centre for Salmonella reported to Santé publique France an excess of Salmonella enterica serotype Dublin (S. Dublin) infections. We investigated to identify the source of infection and implement control measures. Whole genome sequencing (WGS) and multilocus variable-number tandem repeat analysis (MLVA) were performed to identify microbiological clusters and links among cases, animal and food sources. Clusters were defined as isolates with less than 15 single nucleotide polymorphisms determined by WGS and/or with identical MLVA pattern. We compared different clusters of cases with other cases (case-case study) and controls recruited from a web-based cohort (case-control study) in terms of food consumption. We interviewed 63/83 (76%) cases; 2,914 controls completed a questionnaire. Both studies' findings indicated that successive S. Dublin outbreaks from different sources had occurred between November 2015 and March 2016. In the case-control study, cases of distinct WGS clusters were more likely to have consumed Morbier (adjusted odds ratio (aOR): 14; 95% confidence interval (CI): 4.8-42) or Vacherin Mont d'Or (aOR: 27; 95% CI: 6.8-105), two bovine raw-milk cheeses. Based on these results, the Ministry of Agriculture launched a reinforced control plan for processing plants of raw-milk cheeses in the production region, to prevent future outbreaks.Entities:
Keywords: France; Salmonella Dublin; WGS; cheese; outbreaks; raw-milk
Mesh:
Year: 2019 PMID: 30670140 PMCID: PMC6344836 DOI: 10.2807/1560-7917.ES.2019.24.3.1700703
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Figure 1Flowchart of human and non-human Salmonella Dublin isolatesa subtyped and included in the study, France, 2015–2016 (n = 289)
Characteristics of Salmonella Dublin outbreak cases, France, November 2015–March 2016 (n = 83, including 63 interviewed cases)
| Characteristics of cases | Category | n | Na | % |
|---|---|---|---|---|
| Sex | Female | 44 | 83 | 53 |
| Age | 1–17 | 6 | 83 | 7 |
| 18–44 | 10 | 83 | 12 | |
| 45–64 | 19 | 83 | 23 | |
| 65–84 | 31 | 83 | 37 | |
| 85–94 | 17 | 83 | 21 | |
| Region of residence | Auvergne-Rhône-Alpes | 8 | 83 | 10 |
| Bourgogne-Franche-Comté | 19 | 83 | 23 | |
| Bretagne | 6 | 83 | 7 | |
| Grand-Est | 6 | 83 | 7 | |
| Haut-de-France | 7 | 83 | 8 | |
| Île-de-France | 9 | 83 | 11 | |
| Nouvelle-Aquitaine | 9 | 83 | 11 | |
| Pays-de-la-Loire | 7 | 83 | 8 | |
| Otherb | 12 | 83 | 15 | |
| Type of human sample | Blood | 39 | 83 | 47 |
| Stool | 25 | 83 | 30 | |
| Urine | 11 | 83 | 13 | |
| Articular fluid | 3 | 83 | 4 | |
| Pus | 2 | 83 | 2 | |
| Other | 3 | 83 | 4 | |
| Deceased | Yesc | 10 | 83 | 12 |
| Comorbidities | Yesd | 39 | 59 | NA |
| Clinical symptomse | Feverf | 38 | 55 | NA |
| Nausea | 15 | 45 | NA | |
| Vomiting | 19 | 51 | NA | |
| Abdominal pain | 27 | 47 | NA | |
| Diarrhoea | 30 | 56 | NA | |
| Blood in faeces | 5 | 38 | NA | |
| Hospitalisation | Yes | 41 | 60 | 68 |
NA: Not applicable due to low figure in the denominator (< 60).
a Number of cases for which the information was available.
b Centre Val-de-Loire, Normandie, Occitanie and Provence-Alpes-Côte d’Azur.
c Information provided by the National Reference Center for Salmonella (NRC), without confirmation that cause of death was attributable to S. Dublin infection.
d Asthma, cancer, cardiac problems, diabetes, renal failure.
e Cases could have more than one clinical symptom.
f Fever was defined as body temperature > 38°C or perception of having fever.
Figure 2Number of cases by reporteda date of onset of symptomsb, Salmonella Dublin outbreak, France, November 2015–March 2016 (n = 83b)
Number of subtyped human and non-human Salmonella Dublin isolates by MLVA patterns (rows) and whole genome sequencing clusters (columns) included in the study, France, 2015–2016a (n = 289)
| MLVA | WGS | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| A | B | C3 | Cother | F | K | Otherb | ||
| 0 | 0 | 0 | 1 | 19c | 0 | 0 | 20 | |
| 0 | 9d | 0 | 6 | 0 | 0 | 0 | 15 | |
| 0 | 14e | 28 | 3 | 0 | 0 | 2 | 47 | |
| 0 | 0 | 0 | 22f | 0 | 0 | 0 | 22 | |
| 1 | 4 | 1 | 18g | 0 | 0 | 3 | 27 | |
| 0 | 0 | 0 | 10 | 0 | 0 | 0 | 10 | |
| 15 | 1 | 0 | 0 | 0 | 0 | 1 | 17 | |
| 0 | 5 | 1 | 11 | 15 | 11 | 40 | 83 | |
| 2 | 2 | 5 | 17 | 4 | 0 | 18 | 48 | |
| 18 | 35 | 35 | 88 | 38 | 11 | 64 | 289 | |
MLVA: multilocus variable-number tandem repeat analysis; WGS: whole genome sequencing.
a While the study was conducted between 2015 and 2016, the subtyped isolates included historical strains isolated between 1929 and 2014.
b There were 23 other WGS subtypes.
c Among these 19, 13 were associated with WGS subcluster F4.
d All nine isolates with MLVA 17–8-10–7-5–4 pattern were associated with WGS subcluster B3.
e Eight isolates with MLVA 18–8-10–7-5–4 pattern were associated with WGS subcluster B4.
f Fourteen isolates with MLVA 19–8-10–7-5–3 pattern were associated with WGS subcluster C8.
g Eight isolates with MLVA 19–8-10–7-5–4 pattern were associated with WGS subcluster C6.
h There were 42 other MLVA patterns.
Figure 3Phylogenetic analysis of all the subtyped human and non-human Salmonella Dublin isolates included in the study that were whole genome sequenced, France, 2015–2016a (n = 289)
Frequency of reported cheese consumptiona according to MLVA and whole genome sequencing clusters for the case–case study and the case–control study, Salmonella Dublin outbreak, France, November 2015–March 2016 (n cases = 58; n controls = 2,914)
| Type of cheese | Cluster cases | Other casesb | Controls | Case–case studyc | Case–control studyd | Cluster cases | Other casesb | Controls | Case–case studyc | Case–control studyd | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | OR | 95% CI | aORe | 95% CI | n | % | n | % | n | % | OR | 95% CI | aORe | 95% CI | |
| Type of cheese | MLVA 20–8-10–7-5–4 (n = 10 cases) | WGS A (n = 11 cases) | ||||||||||||||||||
| Vacherin Mont d'Or | 7 | 70 | 11 | 31 | 233 | 8 | 5.1 | 0.9–35 | 27 | 6.8–104 | 7 | 70 | 12 | 32 | 233 | 8 | 5.1 | 0.9–34 | 27 | 6.8–105 |
| Comté | 6 | 67 | 21 | 58 | 1,386 | 48 | 1.4 | 0.3–10.2 | NS | NA | 6 | 67 | 23 | 59 | 1,386 | 48 | 1.4 | 0.2–9.8 | NS | NA |
| Gruyère | 7 | 78 | 26 | 76 | 1,841 | 63 | 1.1 | 0.2–13 | NS | NA | 7 | 78 | 28 | 78 | 1,841 | 63 | 1.0 | 0.1–12 | NS | NA |
| Camembert | 6 | 67 | 23 | 66 | 756 | 26 | 1.0 | 0.2–7.6 | NS | NA | 6 | 67 | 25 | 66 | 756 | 26 | 1.0 | 0.2–7.5 | NS | NA |
| Type of cheese | MLVA 18–8-10–7-5–4 (n = 23 cases) | WGS C3 (n = 17 cases) | ||||||||||||||||||
| Morbier | 12 | 60 | 10 | 42 | 361 | 12 | 2.1 | 0.5–8.3 | 11 | 4.2–29 | 10 | 67 | 12 | 37 | 361 | 12 | 3.3 | 0.8–15 | 14 | 4.8–42 |
| Goat cheese | 9 | 53 | 13 | 54 | 1,384 | 47 | 1.0 | 0.2–4.0 | NS | NA | Not consumed by 50% of the cases | NA | NA | NA | NA | |||||
| Camembert | 12 | 63 | 17 | 68 | 756 | 26 | 0.8 | 0.2–3.4 | NS | NA | 11 | 73 | 20 | 62 | 756 | 26 | 1.6 | 0.4–8.7 | NS | NA |
| Gruyère | 13 | 68 | 20 | 83 | 184 | 63 | 0.4 | 0.1–2.3 | NS | NA | 10 | 71 | 25 | 81 | 184 | 63 | 0.6 | 0.1–3.6 | NS | NA |
| Comté | Not consumed by 50% of the cases | NA | NA | NA | NA | 7 | 50 | 22 | 65 | 1,386 | 48 | 0.5 | 0.1–2.3 | NS | NA | |||||
aOR: adjusted odds ratio; CI: confidence interval; MLVA: Multilocus variable-number tandem repeat analysis; NA: not applicable; NS: did not remain significant in the final logistic regression model; OR: odds ratio; WGS: whole genome sequencing.
a Only cheeses consumed by at least 50% of the cases are included in the analysis; cases and controls could report more than one cheese consumed.
b Cases who belong to the other known subtypes.
c Compares cluster cases with other cases with other known subtypes.
d Compares cluster cases with controls.
e Adjusted for age and sex.